Comparative and Efficacy Study of ACTHar Gel Alone or in Combination With Tacrolimus in Fibrillary Glomerulopathy (FACT)

NCT04080076 PHASE4 WITHDRAWN

Treatment with combination ACTHar gel and Tacrolimus therapy or ACTHar gel therapy alone in lowering urinary protein to creatinine (UP/Cr) ratios

Details

Lead sponsor	NephroNet, Inc.
Phase	PHASE4
Status	WITHDRAWN
Start date	Sat Jan 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Sep 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Renal Disease

Interventions

• Acthar 80 UNT/ML Injectable Solution
• Oral Tab Tacrolimus

Countries

United States